Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019829 (
Hodgkin's disease
)
30,247
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The existence, diagnostic features, and the biological and clinical relevance of lymphocyte-rich classical
Hodgkin's lymphoma
remain controversial. A comparative marker analysis of lymphocyte-rich classical
Hodgkin's lymphoma
, nodular lymphocyte-predominance
Hodgkin's lymphoma
, and of other subtypes of classical
Hodgkin's lymphoma
was carried out. Markers were selected focusing on B-cell lineage and transcription program (OCT.1, OCT.2, BOB.1, BCL6, PAX-5, GCET1,
KLHL6
, and BLIMP1), the NF-kappaB signaling pathway (REL-B, C-REL, TRAF-1, p-50, and MUM-1) and the T-cell microenvironment (CD3, CD57, PD-1, CXCL-13, and CD10, BCL-6, CD23). Lymphocyte-rich classical
Hodgkin's lymphoma
cases displayed features intermediate between those of classical
Hodgkin's lymphoma
and nodular lymphocyte-predominance
Hodgkin's lymphoma
. The expression of B-cell transcription factors such as OCT.1, OCT.2, BOB.1, and BCL6 was more frequent in lymphocyte-rich classical
Hodgkin's lymphoma
than in classical
Hodgkin's lymphoma
. A follicular T-cell microenvironment was also identified in 50% of lymphocyte-rich classical
Hodgkin's lymphoma
cases. NF-kB markers were expressed at frequencies comparable with those observed in classical
Hodgkin's lymphoma
. The neoplastic cell immunophenotype and microenvironment in lymphocyte-rich classical
Hodgkin's lymphoma
closely mimic that which are observed in the outer zone of the germinal center, where B-cell blasts with germinal-center markers co-express CD30 and the B-cell transcription program, surrounded by follicular T-cell rosettes. Lymphocyte-rich classical
Hodgkin's lymphoma
seems to be characterized by a stronger expression of the B-cell transcription program by the neoplastic cells and by a follicular T-cell background, occupying an intermediate position between classical
Hodgkin's lymphoma
and nodular lymphocyte-predominance
Hodgkin's lymphoma
.
...
PMID:Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. 1946